- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03276208
Pregnancy, Mindfulness, and Massage
January 27, 2020 updated by: Yale University
Pregnancy Massage and Mindfulness Study for Tobacco Smoking Women
This trial will examine the contribution of massage therapy and mindfulness to tobacco-smoking women in the third trimester of pregnancy.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Massage therapy may be a viable approach to decrease stress during pregnancy that may in turn reduce tobacco consumption.
Massage therapy may not be sufficient as a stand-alone approach, and may be better suited partnered with a cessation approach that targets another mechanism of addiction, craving.
Therefore, participants (N=60) will be enrolled in the Craving to Quit® tobacco cessation program, designed by researchers at Yale, which employs a mindfulness-based approach to train participants to recognize and bring cravings into their conscious awareness.
Each mother will be randomly assigned to a bi-weekly massage intervention (n=30) or control (n=30) group.
Participants in the intervention group will receive two prenatal massages a week for a three-week period.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale Child Study Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- currently pregnant in third trimester
- singleton pregnancy
- aged 18 years or older
- women smoked before their pregnancy
- women who currently smoke at least 5 cigarettes per day at enrollment
- women need access to a smartphone
- women expressing an interest in learning skills to help decrease tobacco-smoking
Exclusion Criteria:
- incapable of giving informed consent
- insufficient English fluency
- participating in other smoking cessation programs
- evidencing severe psychiatric symptoms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Massage Therapy and Mindfulness
Participants in the intervention group will receive two prenatal massages a week for a three-week period.
They will also be enrolled in the mindfulness-based Craving to Quit® tobacco cessation program during this 3-week period.
|
We will utilize moderate pressure Swedish massage (SM) that utilizes long slow strokes known as effleurage and kneading strokes known as petrissage.
A specific routine will be performed on each participant with focus on low back, upper back, shoulders, and neck musculature.
Consistent moderate pressure, which is lighter than deep tissue massage but deeper than brush strokes, will be used.
The intervention and control group will be enrolled in the Craving to Quit® program, a 21-day mindfulness-based program delivered via a smartphone application (https://www.cravingtoquit.com/).
This program uses a mindfulness-based approach to train people to recognize and be aware of their tobacco cravings.
The program includes videos, online exercises to complete, and a virtual support community.
|
Active Comparator: Mindfulness
Participants will enroll in the mindfulness-based Craving to Quit® tobacco cessation program during the same 3-week period.
A massage will be provided upon completion of the study.
|
The intervention and control group will be enrolled in the Craving to Quit® program, a 21-day mindfulness-based program delivered via a smartphone application (https://www.cravingtoquit.com/).
This program uses a mindfulness-based approach to train people to recognize and be aware of their tobacco cravings.
The program includes videos, online exercises to complete, and a virtual support community.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tobacco Use Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Number of cigarettes smoked in past 24 hours
|
Up to 4 weeks
|
Withdrawal Symptoms Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Mood and Physical Symptoms Scale
|
Up to 4 weeks
|
Nicotine Dependence Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
FTND (Fagerstrom Test for Nicotine Dependence) measure
|
Up to 4 weeks
|
Depression Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
EPDS (Edinburgh Postnatal Depression Scale) measure
|
Up to 4 weeks
|
Anxiety Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Beck Anxiety Inventory
|
Up to 4 weeks
|
Stress Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Perceived Stress Scale
|
Up to 4 weeks
|
Daily Stress Scores Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Diary Measure
|
Up to 4 weeks
|
Daily Tobacco Usage Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Diary Measure
|
Up to 4 weeks
|
Heart Rate Variability Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Maternal heart rate variability measured at rest
|
Up to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neonatal Outcomes
Time Frame: Up to 2 months
|
mode of delivery (including any complications), infant well-being, gestational age, and weight.
|
Up to 2 months
|
Fetal Heart Rate Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
Fetal heart rate measured at rest
|
Up to 4 weeks
|
Engagement with Craving to Quit
Time Frame: Up to 4 weeks
|
Engagement with the Craving to Quit app
|
Up to 4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CO (carbon monoxide) monitoring Change from Baseline to Post-Intervention
Time Frame: Up to 4 weeks
|
breath test
|
Up to 4 weeks
|
MINI (Mini International Neuropsychiatric Interview) Substance Dependence
Time Frame: Enrollment
|
determine other substance use disorders
|
Enrollment
|
Self-Reported Mood at each Massage Therapy Session for Intervention Group
Time Frame: Up to 3 weeks
|
positive and negative mood, including stress
|
Up to 3 weeks
|
Mind-mindedness related to infant
Time Frame: Up to 2 months
|
Describe your child measure; this will be a narrative statement provided by participants where they are asked to describe their child.
These narratives will be scored to ascertain the total number of mind-minded comments included in the narrative.
|
Up to 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Paidas, MD, Yale University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 27, 2017
Primary Completion (Actual)
January 24, 2020
Study Completion (Actual)
January 24, 2020
Study Registration Dates
First Submitted
August 20, 2017
First Submitted That Met QC Criteria
September 6, 2017
First Posted (Actual)
September 8, 2017
Study Record Updates
Last Update Posted (Actual)
January 29, 2020
Last Update Submitted That Met QC Criteria
January 27, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2000021692
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
Vanderbilt University Medical CenterCompletedTobacco Use | Tobacco Use Cessation
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
British American Tobacco (Investments) LimitedCompletedTobacco Use | Tobacco SmokingUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
Philip Morris Products S.A.CompletedSmoking | Tobacco Use | Tobacco SmokingUnited Kingdom
Clinical Trials on Prenatal Massage
-
Ege UniversityCompletedPregnancy Related | Fetus Fetus | Massage TherapyTurkey
-
University of Illinois at ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Behavior | Childhood Trauma | Maternal Psychological DistressUnited States
-
Oswaldo Cruz FoundationMontefiore Medical CenterUnknown
-
Hamilton Health Sciences CorporationMcMaster UniversityCompleted
-
Turku University HospitalUniversity of Turku; Academy of Finland; Foundation for Paediatric Research,... and other collaboratorsCompletedSubstance-Related Disorders | Depression | Anxiety | Pregnancy, High Risk | Parenting | Maternal-Fetal Relations | Prenatal Care | Fetal Exposure During Pregnancy | Perinatal OutcomeFinland
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Yale UniversityUnited Health FoundationCompletedSexually Transmitted Diseases | Premature Birth | Pregnancy | Infant, Low Birth Weight | Postpartum PeriodUnited States
-
Universiteit AntwerpenUnknownCongenital Heart Disease in PregnancyBelgium
-
University of VirginiaNamrita OdackalCompletedPremature Birth | Prenatal StressUnited States
-
University Medical Centre MariborRecruiting